COMPASS Pathways
About:
Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.
Website: https://compasspathways.com
Twitter/X: COMPASSPathway
Top Investors: Hercules Capital, RA Capital Management, Perceptive Advisors, Founders Fund, ATAI Life Sciences
Description:
Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression. The company is involved in researching and developing psilocybin therapy, a psychedelic compound found in certain mushrooms, as a potential treatment for depression. Compass Pathways conducts clinical trials and research to assess the safety and efficacy of psilocybin-assisted therapy in patients who have not responded to conventional depression treatments. The company's goal is to bring evidence-based innovation to mental health care and address the significant unmet need for effective and accessible treatments for depression.
$271M
$10M to $50M
Altrincham, Cheshire, United Kingdom
2016-06-13
Ekaterina Malievskaia, George Goldsmith, Lars Christian Wilde
101-250
2023-08-16
Public
© 2025 bioDAO.ai